ArticleJournal of multidisciplinary healthcare2026
Type 2 Diabetes-Related Complications Among Commercial Pilots: Aeromedical Considerations from a Retrospective Cohort.
Article in Journal of multidisciplinary healthcare, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Type 2 diabetes mellitus (T2DM) and diabetes-related complications can pose serious challenges to pilots by affecting their flight performance and professional careers. This study aims to investigate the emergence of complications in commercial pilots with T2DM through a retrospective evaluation of their aeromedical examination records. Patients and Methods: The retrospective cohort study included 59 commercial pilots who had a confirmed diagnosis of T2DM in year 2012, whereas pilots without such diagnosis within that year were excluded from the study. Their examination records involving the first diagnosis of T2DM prior to 2012 and all subsequent records from 2013 to 2021 were comprehensively analyzed. Data included demographic information, smoking status, age of diabetes and complication onset, certain biochemical markers, complications, and aeromedical certification processes. Estimated glomerular filtration rate (eGFR) values were calculated in each record using the CKD- EPI equation, with chronic kidney disease determined as two consecutive eGFR measurements being <60 mL/min/1.73 m Results: Of the 59 pilots, 28 (47.5%) had at least one complication, such as coronary artery disease (CAD), retinopathy, stroke, or diabetic kidney disease (DKD), with 14 of them diagnosed retrospectively by eGFR measurements. The prevalence of smoking was 30.5%, with 77.78% of them developing complications, indicating a significant relationship (p=0.004). The mean age at the diagnosis of T2DM was 50.16±6.62, while complications occurred at 58.64±5.69 years. No significant difference was found in the age of T2DM onset between pilots with complications and those without. Conclusion: This study identified a strong association between smoking and diabetes-related complications, demonstrated a high rate of complications -primarily CAD and DKD- in pilots with T2DM, and underscored the importance of periodical examinations in detecting subclinical conditions. Routine eGFR measurement was also shown to be essential for the early detection of DKD diagnosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.